Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca Pharma India plans to sell Bengaluru facility

Ruchika Sharma17 Nov 2023 3:30 PM IST

Bengaluru: AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of global manufacturing and...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Suresh Babu K resigns as Natco Pharma Vice President

Ruchika Sharma17 Nov 2023 2:30 PM IST

Hyderabad: Natco Pharma has announced that Sri Suresh Babu K, Vice President – Quality Assurance for Chemical Division, Mekaguda of the Company...

Venkat Nageswar Chalasani resigns as Independent Director of Aurobindo Pharma arm Apitoria Pharma

Ruchika Sharma17 Nov 2023 1:30 PM IST

Hyderabad: Through a recent BSE filing, Aurobindo Pharma has recently informed that Venkat Nageswar Chalasani has resigned as the Independent...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

USFDA nod to Pfizer, Astellas Pharma Xtandi for early prostate cancar

Ruchika Sharma17 Nov 2023 12:30 PM IST

Tokyo: Pfizer Inc. and Astellas Pharma Inc. have announced that the companies have received approval from the U.S. Food and Drug Administration...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca breast cancer drug combination gets USFDA okay

Ruchika Sharma17 Nov 2023 11:37 AM IST

Truqap belongs to a class of drugs known as AKT inhibitors and works by targeting the AKT1 gene mutation, which is responsible for growth and...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

USFDA nod to Bristol Myers Squibb Augtyro for lung cancer

Ruchika Sharma16 Nov 2023 5:30 PM IST

Augtyro is designed to minimize interactions that can lead to certain forms of treatment resistance in ROS1-positive metastatic NSCLC patients.

Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US

Ruchika Sharma16 Nov 2023 4:30 PM IST

Dabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal, Revlon, Luster Products and...

Post USFDA warning letter, Amazon removing 7 unapproved eye drops from its e-commerce platform

Ruchika Sharma16 Nov 2023 3:30 PM IST

The eye drops flagged in the letter to Amazon include Similasan Pink Eye Relief, Can-C Eye Drops, Optique 1 Eye Drops and OcluMed Eye Drops, among...

IHH healthcare unit drags Daiichi Sankyo to court over Fortis Healthcare deal, claims 20 billion yen as damages

Ruchika Sharma16 Nov 2023 2:30 PM IST

NTK is also seeking an injunction to prevent Daiichi from making defamatory remarks against it with respect to the aforesaid open offers, it noted.

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

USFDA staff flags concerns about Merck chronic cough drug

Ruchika Sharma16 Nov 2023 1:25 PM IST

Staff assessment of the data submitted by Merck showed a small reduction in cough frequency and side effects such as loss of taste in patients who...

Gland Pharma bags tentative USFDA nod for Angiotensin II Injection for low BP treatment

Ruchika Sharma16 Nov 2023 11:43 AM IST

Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received tentative approval from the United States Food and...

Natco Pharma posts over six-fold jump in consolidated net profit to Rs 369 crore in Q2

Ruchika Sharma16 Nov 2023 10:00 AM IST

Hyderabad: Natco Pharma has reported an over six-fold jump in its consolidated net profit to Rs 369 crore in the second quarter ended September 30,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok